All Articles

6 articles

Browse the latest research, analysis, and insights on healthspan, lifespan, and the longevity industry.

Yamanaka Factors at Scale: The Race to Reprogram Aging

Partial cellular reprogramming has reversed aging in mice. Now the hard work begins: making it safe for humans.

Dr. James Liu · Feb 7, 2026 · 10 min read

The world's best-funded longevity company has been notably quiet. Here's what we know about what they're building.

Marcus Webb · Jan 28, 2026 · 8 min read

The most promising longevity drug is finding its way into wellness clinics and biohacker forums. Here's what the science actually says.

Dr. Sarah Chen · Jan 25, 2026 · 18 min read

Continuous glucose monitors were designed for diabetics. Now they're the must-have wearable for the metabolically curious.

Marcus Webb · Jan 20, 2026 · 7 min read

Investment in aging research companies surges as institutional investors bet big on healthspan extension technologies.

Editorial Team · Feb 10, 2024 · 6 min read

From cellular reprogramming to AI-powered drug discovery, these companies are pushing the boundaries of aging research.

Sarah Chen · Feb 5, 2024 · 8 min read